IPAImmunoPrecise AntibodiesIPA info
$0.66info13.99%24h
Global rank30690
Market cap$17.37M
Change 7d-
YTD Performance-59.51%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Business data

    ImmunoPrecise Antibodies (IPA) Stock Overview

    ImmunoPrecise Antibodies Ltd., together with its subsidiaries, operates as a biotherapeutic research and technology company in Canada and internationally. It provides NonaVac DNA for complex protein classes, including GPCRs and ion channels; and Rapid Prime, a positive monoclonal antibodies for generating anti-idiotypic antibodies, and producing monoclonal antibodies against conformational epitopes. The company also offers syngeneic cell line for immunization and screening; and peptide production for subsequent antibody discovery campaign. In addition, it provides B cell select platform which allows for the interrogation of animal antibody repertoire; screening of the immune repertoire of rabbits and chickens and select the desired antibody directly from the B cells; single step hybridoma, a semi-solid media to grow mouse and rat hybridomas; and DeepDisplay, a combination of transgenic animal platform and custom IPA phage display antibody selection. The company also offers phage display, a custom immune libraries from multiple species; and CAR development, an adaptable antibody which allows the inclusion of functional data early in the screening funnel. Further, it provides silico developability, a profiling toolset for antibody lead candidates; and vitro analytical tools for the study of various critical quality attributes. Additionally, the company offers LucinaTech, an antibody humanization to identify essential framework and CDR residues; antibody affinity maturation for therapeutic and diagnostic application; and antibody chimerization for cloning and production of variable antibody domain. It also provides Eurofins preclinical services; hybrid service model, a service model designed to reduce time and risk with custom technologies and applications; and breadth and depth to accelerate assay development, screening cascades, drug candidate validation, and new biotherapeutic concepts. The company was incorporated in 1983 and is headquartered in Victoria, Canada.

    IPA Stock Information

    Symbol
    IPA
    Address
    3204–4464 Markham StreetVictoria, BC V8Z 7X8Canada
    Founded
    -
    Trading hours
    -
    Website
    https://www.ipatherapeutics.com
    Country
    🇨🇦 Canada
    Phone Number
    250-483-0308

    ImmunoPrecise Antibodies (IPA) Price Chart

    -
    Value:-

    ImmunoPrecise Antibodies Overview: Key Details and Summary

    Stock data
    2024
    Change
    Price
    $0.66
    N/A
    Market Cap
    $17.37M
    N/A
    Shares Outstanding
    26.32M
    N/A
    Employees
    102.00
    N/A
    logo
    Facebook Icon
    Twitter Icon
    Linkedin Icon
    © 2024 Topstocks.org